Intera Atlas
Run match
Sites / Southern Endocrinology Associates
Is this you?

Request access for Southern Endocrinology Associates with your @bitrialsupport.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Southern Endocrinology Associates

Unclaimed profile

Independent Site · Mesquite, Texas · ~1 sites

Rank for protocol
Intera lens
ICP 6Lift (cardio sample) 0.36Recruit soph 0.14
Quality Scorecard (1–100)
Overall64Recruit59Ops74Sponsor59Ther62

Performance (observed)

Historical trials
174
Completed
107
Terminated/Withdrawn
14
Completion rate
88%
Active now
50
Phase 2
27
Phase 3
129
Realized enrollment
416,211
First study year
2000
Years active
26
Match confidence
high
Enrollment velocity (inf)
16,008

Therapeutic

Areas
Endocrinology, Diabetes (Type I & II), Obesity, Overweight, Coronary disease, Myocardial infarction, Metabolic syndrome, Thyroid, Osteoporosis
Breadth (conditions)
97
States
Texas

Recruitment (web observed)

Advertises recruitment
Yes
Capability notes
Single-site endocrinology research program; experienced research staff (dedicated coordinators and nurses)

Relationships

Sponsors
Eli Lilly and Company; Novo Nordisk A/S; Boehringer Ingelheim; Amgen; Pfizer; Novartis Pharmaceuticals
CROs
ICON Clinical Research
Owner / parent
Private endocrinology practice (Dr. Sumana Gangi, PI)

Capacity & people

Investigators
—
Coordinators
—
VP Clinical Ops
Dr. Sumana Gangi (Principal Investigator)
VP Site Ops
Gary Noworatzky (Sub-PI, 30+ years PA experience)
Emails
unitedstates@bitrialsupport.com

Tech & DCT

Builds tech
Vendors (clinical study management systems)
Tech stack
Clinical trial coordination systems; study management infrastructure
Recruiting visible
Y

Notes

Endocrinology-focused site with 6 active recruiting cardiometabolic trials confirmed (ClinicalTrials.gov validation). Single Mesquite, Texas location. Specialized in diabetes (Type I & II) and metabolic disorders research. Experienced research team: Dr. Sumana Gangi (PI) and Gary Noworatzky (Sub-PI with 30+ years PA experience in primary care and endocrinology), 3 study coordinators, 2 study nurses. Historically excellent trial execution and patient enrollment. Score reflects: cardiometabolic specialization, experienced clinical research team, endocrinology expertise, consistent trial enrollment; limited by single-site constraint, no website, and independent rather than network model.

Recommendation features (sample indication)

Ind fit 0.42Liftability 0.36Overall64

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.